Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek to maintain revenue streams and competitive advantages. In this edition of Beyond the Deal, our lawyers assess the evolving landscape, share insights on the impacts of strategic deals and explain how they can shape the future of drug development and commercialization.

Read what our partners have to say.

Photo of Fangli Chen Fangli Chen

Dr. Fangli Chen is a partner in the Litigation Department and chair of the Life Sciences Patent Practice. She represents all types of companies in the biotech and pharmaceutical industries, and has deep scientific expertise and a strong business sense. Fangli effectively identifies…

Dr. Fangli Chen is a partner in the Litigation Department and chair of the Life Sciences Patent Practice. She represents all types of companies in the biotech and pharmaceutical industries, and has deep scientific expertise and a strong business sense. Fangli effectively identifies and transforms technological developments into valuable intellectual property assets for her clients and specializes in the strategic development of complex IP portfolios for companies that align with their business goals.

Fangli’s practice also focuses on post-grant review before the USPTO, oppositions, pre-litigation and litigation strategy, due diligence investigations, freedom-to-operate, non-infringement and invalidity analysis, licensing and other IP matters in connection with commercial transactions. She handles a variety of technology areas including biochemistry, molecular and cell biology, immunotherapy, enzyme replacement therapy, nucleic acid based technologies including messenger RNA therapy, gene therapy, gene editing, antisense and oligonucleotides based therapies, vaccines, bioinformatics, and small molecule compound drugs.

Fangli also has a wealth of experience in the following areas:

  • Post-grant challenges: representing clients in inter partes review interference and various foreign opposition proceedings.
  • Technology transactions & licensing: advising clients on matters relating to technology or material transfer, licensing and research collaborations.
  • Investment or acquisition counsel: assisting investors in assessing the technology and intellectual property assets and risks for potential target investments and counseling companies on intellectual property matters in connection with public offering or acquisition.

Fangli has been repeatedly noted for her top-tier work by industry publications, including being listed as a World’s Leading Patent Practitioner by IAM Patent 1000 and recognized as one of the Top 250 Women in IP nationwide by Managing Intellectual Property. In 2019, she was named Patent Strategy & Management Attorney of the Year in Massachusetts by LMG Life Sciences. She has also been recognized by Best Lawyers in America, Client Choice, Legal 500, Massachusetts Lawyers Weekly and Massachusetts Super Lawyers. Prior to joining Proskauer, Fangli was a partner at a leading Boston law firm.

Read more about Fangli ChenEmail
Show more Show less
Photo of Laura E. Goldsmith Laura E. Goldsmith

Laura Goldsmith is a partner in the Technology, Media and Telecommunications Group and member of the Privacy & Cybersecurity Group and Life Sciences Group. Her practice focuses on matters in technology, intellectual property, privacy and data protection across a range of industries including…

Laura Goldsmith is a partner in the Technology, Media and Telecommunications Group and member of the Privacy & Cybersecurity Group and Life Sciences Group. Her practice focuses on matters in technology, intellectual property, privacy and data protection across a range of industries including life sciences, media, entertainment, sports, sports betting, software, professional and financial services, healthcare, retail, fashion and communications.

Laura structures and negotiates complex technology transactions, such as license agreements, joint development agreements, supply, manufacturing or other services agreements, and software-as-a-service agreements.  In particular, she regularly represents life science companies in licensing deals, co-commercialization arrangements, research collaborations, strategic acquisitions, and other transactions.

Laura also counsels clients in navigating compliance with international, federal and state laws related to privacy and data protection in the context of transactions, vendor relationships, internal compliance and external-facing policies.  She is an editor of and contributor to Proskauer’s Privacy Law Blog and contributor to the State Privacy Laws and Financial Privacy chapters of the Proskauer on Privacy treatise published by PLI.

Laura is a member of the Proskauer Women’s Alliance Steering Committee and previously served as its co-chair.

Prior to her legal career, Laura worked as a consultant to global pharmaceutical companies formulating drug development strategy and clinical trial design. She also conducted scientific research in pharmacology and biology at Duke University Medical Center and her research has been published in peer-reviewed journals.

While at Boston University School of Law, Laura served as the Editor-in-Chief for the Review of Banking & Financial Law and interned for Judge Kiyo A. Matsumoto of the U.S. District Court for the Eastern District of New York.

Read more about Laura E. GoldsmithEmail
Show more Show less
Photo of Daryn Grossman Daryn Grossman

Daryn A. Grossman is a partner in our Corporate Department and head of the Life Sciences Group.

Daryn is the former Managing Partner and continues to participate in the leadership of the firm in various capacities, working closely with the Firm’s Chair and…

Daryn A. Grossman is a partner in our Corporate Department and head of the Life Sciences Group.

Daryn is the former Managing Partner and continues to participate in the leadership of the firm in various capacities, working closely with the Firm’s Chair and Executive Committee in relation to the implementation of the Firm’s business strategy.

Over the course of her career, Daryn has served in several leadership positions including co-chair of Proskauer’s global Corporate Department, the Firm’s largest department, and as co-head of the Technology, Media & Telecommunications Group. She has also served on the Firm’s Hiring Committee, Business Development Committee and Lateral Acquisition Committee.  Daryn has championed the career of many women lawyers throughout the Firm and actively engages in the Proskauer Women’s Alliance programming.

As a tech-transactional lawyer, Daryn has designed and negotiated complex technology and intellectual property transaction structures, including strategic alliances, licensing, technology development and outsourcing transactions. Her clients include a wide range of life sciences, cloud computing, digital media, Internet, software, electronics, luxury goods, retail, fashion, entertainment, telecommunications and clean technology companies.

Daryn’s practice also focuses on technology mergers, acquisitions, sales and spinoffs. She represents both growth and mature companies, and counsels venture capitalists and strategic investors in evaluating intellectual property portfolios in connection with private equity investments, public offerings and mergers and acquisitions. Daryn often counsels boards of directors and management teams in navigating the critical commercial and legal issues surrounding product development and exploitation and risk mitigation.

Clients describe Daryn as “skilled and resourceful.” IAM Patent writes: “In the IP monetization area, there is nothing crack negotiator Daryn Grossman can’t do,” adding that she has “a command of all deal types across the IP commercialization spectrum…she can go toe to toe with anybody. She just gets deals done.”

Read more about Daryn GrossmanEmail
Show more Show less
Photo of Baldassare Vinti Baldassare Vinti

Baldassare (“Baldo”) Vinti heads Proskauer’s Intellectual Property Litigation Group.

Baldo’s practice focuses on litigating patent, false advertising, trade secret, life sciences, trademark and contractual matters in federal and state courts and before the International Trade Commission. He is a seasoned trial attorney responsible…

Baldassare (“Baldo”) Vinti heads Proskauer’s Intellectual Property Litigation Group.

Baldo’s practice focuses on litigating patent, false advertising, trade secret, life sciences, trademark and contractual matters in federal and state courts and before the International Trade Commission. He is a seasoned trial attorney responsible for all aspects of litigation, including Markman hearings, appeals before the Federal Circuit, case preparation and strategy, depositions, motion practice, and settlement negotiations. He has represented clients in high-stakes matters involving a broad range of technologies, including medical devices, diagnostics, immunoassays, prosthetics, pharmaceuticals, dental implants, electronic medical records systems, encryption technology, wound dressings, digital video compression, electronic book delivery and security systems, mobile media technologies, navigation and location-based services, bandwidth management, bar code scanning, lasers , and other technologies. Baldo has represented numerous major corporations, including Arkema S.A., British Telecommunications PLC, Church & Dwight Co., Inc., Henry Schein, Inc., Maidenform Brands Inc., Mitsubishi Electric Corp., Ossur North America Inc., Panasonic Corp., Sony Corp., Welch Foods, Inc., and Zenith Electronics LLC.

In addition, Baldo regularly handles transactional work, including intellectual property due diligence, licensing, intellectual property structural transactions, patentability studies, infringement/non-infringement opinions, and client counseling in intellectual property matters.

Baldo is an author and frequent commentator on patent issues pertaining to medical devices and a host of other intellectual property topics, and has been quoted in the National Law Journal, Bloomberg BNA, Law360, Westlaw Journal and Inside Counsel magazine. He is also a regular contributor of articles published in Medical Product Outsourcing magazine that deal with the medical device industry.

Baldo served as a judicial intern for Hon. John E. Sprizzo of the United States District Court for the Southern District of New York and for Hon. Charles A. LaTorella of the New York Supreme Court.

Read more about Baldassare VintiEmail
Show more Show less